Funding Raises: #Metropolis $500M Series D; #Ripple $500M Strategic; #Armis $435M pre-IPO Funding; #BillionToOne $273.1M IPO; #BeaconSoftware $250M Series B; #Synchron $200M Series D; #BraveheartBio $185M Series A; #Evommune $150M IPO; : #HippocraticAI $126M Series C

Braveheart, AAVantgarde rounds head recent biofinancings Our latest crop of biotech financings has nine-figure rounds for Braveheart and AAVantgarde, with Azalea Therapeutics and NEOK Bio also raising funds.

Our round-up of #biotech #financings is led this week by #BraveheartBio, a San Francisco biotech that has launched with $185 million, a lead drug for hypertrophic #cardiomyopathy (HCM), and Biogen CEO Chris Viehbacher as its chair.

pharmaphorum.com/news/bravehe...